An Integrated Management Framework for AI-Assisted Pharmaceutical Synthesis Route Selection
An Integrated Management Framework for AI-Assisted Pharmaceutical Synthesis Route Selection
Elham Afzali1
1) PhD in Organic Chemistry, Science and Research Branch, Islamic Azad University, Tehran, iran
IOI Code
:
ACZF-ACAFFE
Publication :
6th.International Congress on Management, Economy, Humanities, Education and Business Development(6icmba.ir)
Abstract :
Artificial intelligence expands the range of candidate routes for active pharmaceutical ingredient synthesis, creating valuable opportunities to support decision-making in drug development and manufacturing. This study develops an integrated framework for managing synthesis route selection based on cost, safety, and industrial manufacturability. The research adopts a conceptual framework development approach based on the analysis and synthesis of previous research and specialist guidance. The proposed framework connects AI-assisted synthesis planning with process economics, pharmaceutical quality risk management, and industrial manufacturing requirements. Its structure comprises a common assessment boundary, an evidence register, acceptance gates, comparison of eligible alternatives, and sensitivity analysis. The proposed innovation lies in integrating evidence-based acceptance with managerial preference assessment while displaying evidence maturity alongside route scores within a traceable and auditable decision architecture. The framework’s application is illustrated through a hypothetical four-route example. Analytical results demonstrate how jointly examining acceptance conditions and managerial priorities provides an explicit basis for shortlisting alternatives, identifying development needs, and interpreting ranking changes. The framework also organizes specialist responsibilities, decision documentation, and authorization appropriate to the development stage. The study contributes a coherent mechanism for translating AI-generated proposals into documented managerial recommendations, providing a foundation for future implementation and evaluation in pharmaceutical process development projects.
Keywords : artificial intelligence retrosynthesis production cost safety scale up